Results 131 to 140 of about 58,406 (311)

Does Type of Infant Feeding Affect Phototherapy for Neonatal Hyperbilirubinemia? [PDF]

open access: bronze, 2012
Abeer El Sakka   +3 more
openalex   +1 more source

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

open access: yesAmerican Journal of Hematology, Volume 101, Issue 2, Page 242-254, February 2026.
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth   +13 more
wiley   +1 more source

Comparing the effect of clofibrate and phenobarbital on the newborns with hyperbilirubinemia [PDF]

open access: yes, 2013
The aim of treating hyperbilirubinemia is preventing the serum bilirubin to reach neurotoxic levels, which is done by phototherapy or blood transfusion. However, pharmacological treatments still remain vague.
Hamidi, Majid   +2 more
core  

Carboxyhemoglobin blood level in indirect hyperbilirubinemia in term and late-preterm infants as a marker of hemolysis

open access: yesEgyptian Pediatric Association Gazette
Background Neonatal hyperbilirubinemia remains one of the most common clinical conditions faced and one of the most common diagnoses requiring neonatal intensive care unit (NICU) admission, and this study aims to investigate whether carboxyhemoglobin ...
Dina Rabie   +3 more
doaj   +1 more source

Investigation of the relationship between cord clamping time and risk of hyperbilirubinemia [PDF]

open access: diamond, 2020
Yüksel Yaşartekin   +7 more
openalex   +1 more source

Pharmacogenomics of Thiopurine Drugs: A Bench‐To‐Bedside Success Story in Thailand

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Thiopurine drugs are the cornerstone treatment for many diseases such as acute lymphoblastic leukemia (ALL), organ rejection, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other autoimmune diseases.
Mohitosh Biswas   +3 more
wiley   +1 more source

Gilbert syndrome in patients with inherited hemolytic anemia modifies the clinical phenotype

open access: yesPediatric Hematology Oncology Journal
Gilbert syndrome is a benign condition due to UGT1A1 mutations frequently resulting in mild, indirect hyperbilirubinemia. Inherited hemolytic anemias often present with hyperbilirubinemia and hepatosplenomegaly.
Anika Agrawal, Jagdish Chandra
doaj   +1 more source

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

open access: yesLiver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim   +15 more
wiley   +1 more source

UGT1A1 and BLVRA allele and genotype variants in neonatal patients with hyperbilirubinemia in southern China

open access: yesScientific Reports
We explore the allele and genotype distribution of UGT1A1 and BLVRA variants in individuals affected by neonatal hyperbilirubinemia in southern China.
XiuJu Liu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy